These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 19810488)

  • 21. High dose rate (HDR) brachytherapy technique: for carcinoma of uterine cervix using Nucletron applicators.
    Nair MT; Cheng MC; Barker A; Rouse BS
    Med Dosim; 1995; 20(3):201-7. PubMed ID: 7576095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose distribution for endovascular brachytherapy using Ir-192 sources: comparison of Monte Carlo calculations with radiochromic film measurements.
    Sureka CS; Sunny CS; Subbaiah KV; Aruna P; Ganesan S
    Phys Med Biol; 2007 Jan; 52(2):525-37. PubMed ID: 17202631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosimetric analysis of a shielded applicator for nasopharyngeal carcinoma intracavitary brachytherapy: Monte Carlo calculation.
    Chen LX; Liu XW; You RA; Qian JY; Qi ZY; Deng XW; Tsao SY
    Med Phys; 2006 Mar; 33(3):761-9. PubMed ID: 16878578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-specific Monte Carlo dose calculations for high-dose-rate endorectal brachytherapy with shielded intracavitary applicator.
    Poon E; Williamson JF; Vuong T; Verhaegen F
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1259-66. PubMed ID: 18954720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosimetric characterization of round HDR 192Ir accuboost applicators for breast brachytherapy.
    Rivard MJ; Melhus CS; Wazer DE; Bricault RJ
    Med Phys; 2009 Nov; 36(11):5027-32. PubMed ID: 19994513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
    Davidson MT; Yuen J; D'Souza DP; Batchelar DL
    Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and characterization of a new high-dose-rate brachytherapy Valencia applicator for larger skin lesions.
    Candela-Juan C; Niatsetski Y; van der Laarse R; Granero D; Ballester F; Perez-Calatayud J; Vijande J
    Med Phys; 2016 Apr; 43(4):1639. PubMed ID: 27036563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and dosimetric characteristics of a high dose rate remotely afterloaded endocavitary applicator system.
    Meigooni AS; Zhu Y; Williamson JF; Myerson RJ; Teague S; Löffler E; Nussbaum GH; Klein EE; Kodner IJ
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1153-63. PubMed ID: 8600101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
    Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY
    Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HDRMC, an accelerated Monte Carlo dose calculator for high dose rate brachytherapy with CT-compatible applicators.
    Chibani O; C-M Ma C
    Med Phys; 2014 May; 41(5):051712. PubMed ID: 24784378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetric Considerations for Ytterbium-169, Selenium-75, and Iridium-192 Radioisotopes in High-Dose-Rate Endorectal Brachytherapy.
    Shoemaker T; Vuong T; Glickman H; Kaifi S; Famulari G; Enger SA
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):875-883. PubMed ID: 31330175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monte Carlo simulations and radiation dosimetry measurements of peripherally applied HDR 192Ir breast brachytherapy D-shaped applicators.
    Yang Y; Rivard MJ
    Med Phys; 2009 Mar; 36(3):809-15. PubMed ID: 19378741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications of applicators orientations on bladder, and rectal doses in gynecological mHDR brachytherapy: A retrospective analysis of reproducibility in multi-fractionated regimen.
    Srivastava AK; Rastogi M; Mishra SP
    J Cancer Res Ther; 2019; 15(6):1345-1351. PubMed ID: 31898671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interstitial rotating shield brachytherapy for prostate cancer.
    Adams QE; Xu J; Breitbach EK; Li X; Enger SA; Rockey WR; Kim Y; Wu X; Flynn RT
    Med Phys; 2014 May; 41(5):051703. PubMed ID: 24784369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-dimensional applicator system for carcinoma of the uterine cervix.
    Weeks KJ; Montana GS
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):455-63. PubMed ID: 9069321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel rectal applicator for contact radiotherapy with HDR
    Bellezzo M; Fonseca GP; Verrijssen AS; Voncken R; Van den Bosch MR; Yoriyaz H; Reniers B; Berbée M; Van Limbergen EJ; Verhaegen F
    Brachytherapy; 2018; 17(6):1037-1044. PubMed ID: 30122346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screens in ovoids of a Selectron cervix applicator.
    Meertens H; van der Laarse R
    Radiother Oncol; 1985 Jan; 3(1):69-80. PubMed ID: 3975442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Monte Carlo calculations around a Fletcher Suit Delclos ovoid with radiochromic film and normoxic polymer gel dosimetry.
    Gifford KA; Horton JL; Jackson EF; Steger TR; Heard MP; Mourtada F; Lawyer AA; Ibbott GS
    Med Phys; 2005 Jul; 32(7Part1):2288-2294. PubMed ID: 28493569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dosimetric comparison between applicators used for brachytherapy in carcinoma cervix - A single-institute prospective study.
    Suryadevara A; Kumar MV; Vasundhara E; Alluri KR; Ahamed S; Guduru S
    Indian J Cancer; 2018; 55(3):230-232. PubMed ID: 30693884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetry of intracavitary placements for uterine and cervical carcinoma: results of orthogonal film, TLD, and CT-assisted techniques.
    Kapp KS; Stuecklschweiger GF; Kapp DS; Hackl AG
    Radiother Oncol; 1992 Jul; 24(3):137-46. PubMed ID: 1410567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.